Animportant aspect to consider in the multiple myeloma (MM) treatmentstrategy is the loss-of-function mutations in the TSC complex resultingin a genetic disorder, tuberous sclerosis complex (TSC), also knownas tuberous sclerosis. The gene discussed is TSC1; the disease is tuberous sclerosis.